USD 2.9
(-2.68%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2022 | 5.41 Billion BRL | 34.8% |
2021 | 4.01 Billion BRL | 36.91% |
2020 | 2.93 Billion BRL | 62.44% |
2019 | 1.8 Billion BRL | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 Q2 | 8.54 Billion BRL | 16.99% |
2023 Q3 | 8.99 Billion BRL | 5.25% |
2023 Q1 | 7.3 Billion BRL | 34.89% |
2022 Q2 | 7.12 Billion BRL | 0.0% |
2022 Q3 | 7.69 Billion BRL | 7.99% |
2022 FY | 5.41 Billion BRL | 34.8% |
2022 Q4 | 5.41 Billion BRL | -29.67% |
2021 Q1 | - BRL | -100.0% |
2021 FY | 4.01 Billion BRL | 36.91% |
2021 Q4 | 4.01 Billion BRL | -24.94% |
2021 Q3 | 5.35 Billion BRL | 0.0% |
2020 Q4 | 2.93 Billion BRL | 0.0% |
2020 FY | 2.93 Billion BRL | 62.44% |
2019 FY | 1.8 Billion BRL | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Bioceres Crop Solutions Corp. | 501.06 Million USD | -980.426% |
Muliang Viagoo Technology, Inc. | 9.29 Million USD | -58123.038% |
N2OFF, Inc. | 785.65 Thousand USD | -688960.819% |
Arcadia Biosciences, Inc. | 7 Million USD | -77215.438% |
Yield10 Bioscience, Inc. | 6.39 Million USD | -84620.297% |